BioSpace News Archive

NetDiligence®, a leading provider of cyber risk readiness and response services, today announced that significant enhancements to its innovative Breach Plan Connect® (BPC) software are being released early next year.

The Parkinson’s Foundation today announced the launch of Newly Diagnosed: Building a Better Life with Parkinson’s Disease, a new campaign designed to arm people who are newly diagnosed with the knowledge, tools and resources they need to navigate life with Parkinson’s disease (PD).

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz

Today at RampUp Chicago, HealthVerity, the trusted foundation for the rapid creation, exchange and management of healthcare and consumer data, and LiveRamp® (NYSE: RAMP) the trusted platform that makes data accessible and meaningful, announced a partnership that will enable the connection of digital behavior with healthcare data in a privacy-centric, HIPAA-compliant manner.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Sarah Boyce to the Company’s Board of Directors, effective today. Ms. Boyce currently serves as President and CEO of Avidity Biosciences, Inc., a privately held biotechnology company pioneering the use of antibody-oligonucleotide conjugates (AOC™) to treat rare muscle disorders and other serious diseases.

Sustained wound healing and favorable safety profile observed at three years post-treatment

Spectrum Retirement Communities, LLC, has added James Robinson to the clinical leadership team.

The national Allwell brand provides Medicare Advantage members access to Superior’s network of valued providers who deliver quality services across a spectrum of care.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced a merger transaction with a public company that is DTC eligible and current with its SEC filings to serve as a vehicle for the quotation of the common stock of its subsidiary NuGenerex Immuno-Oncology (NGIO) as an independent, publicly traded company.

Endocrinologists play crucial role in prevention, diagnosis and management of osteoporosis